DMT-d4

DMT-d4
Clinical data
Other namesD4DMT; [2H4]-DMT; Dimethyltryptamine-d4; α,α,β,β-Tetradeutero-DMT; α,α,β,β-Tetradeutero-N,N-dimethyltryptamine
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • 1,1,2,2-tetradeuterio-2-(1H-indol-3-yl)-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC12H16N2
Molar mass188.274 g·mol−1
3D model (JSmol)
  • [2H]C([2H])(C1=CNC2=CC=CC=C21)C([2H])([2H])N(C)C
  • InChI=1S/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H3/i7D2,8D2
  • Key:DMULVCHRPCFFGV-OSEHSPPNSA-N

DMT-d4, or D4DMT, also known as α,α,β,β-tetradeutero-DMT, is a serotonin receptor modulator and putative psychedelic drug of the tryptamine family related to dimethyltryptamine (DMT). It is the isotopologue of DMT in which the hydrogen atoms at the α and β positions have been replaced with the deuterium isotopes.

Pharmacology

DMT-d4 is thought to be resistant to metabolism by monoamine oxidase (MAO) compared to DMT. Relatedly, D4DMT, at the same dose, shows stronger effects, 2- to 3-fold higher brain levels, a longer duration, and a faster onset than DMT in rodents. In addition, DMT-d4, unlike DMT, might be orally active, though this remains to be studied. D4DMT was said to have similar properties to the combination of DMT with a monoamine oxidase inhibitor (MAOI) in rodents. The metabolism and metabolites of DMT-d4 have been studied.

Chemistry

Synthesis

The chemical synthesis of DMT-d4 has been described.

Analogues

A notable analogue of DMT-d4 is 5-MeO-DMT-d4. Other analogues of DMT-d4 include deuterated forms of tryptamine like α,α-dideuterotryptamine and β,β-dideuterotryptamine.

History

DMT-d4 was first described in the scientific literature by 1982.

See also